EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Renal Cell Cancer and Chronic Kidney Disease

Danielle L Saly, Meghana S Eswarappa, Sarah E Street, Priya Deshpande

Advances in Chronic Kidney Disease · 2021-09 · 28 (5) · 460-468.e1

DOI: 10.1053/j.ackd.2021.10.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Chronic Kidney Disease, 2021-09. Verfasst von Danielle L Saly und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Massachusetts General Hospital, Boston, MA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The association between chronic kidney disease (CKD) and renal cell carcinoma (RCC) is bidirectional and multifactorial. Risk factors such as hypertension, diabetes mellitus, obesity, and smoking increase the risk of both CKD and RCC. CKD can lead to RCC via an underlying cystic disease or oxidative stress. RCC can cause CKD because of the tumor itself, surgical reduction of renal mass (either partial or radical nephrectomy), and perioperative acute kidney injury. Medical therapies such as immune checkpoint inhibitors and vascular endothelial growth factor inhibitors can lead to acute kidney injury and resultant CKD. Clinicians need to be aware of the complex, bidirectional interplay between both diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsRenal Insufficiency, ChronicHumansNephrectomyVascular Endothelial Growth Factor A

Stichwörter der Autor:innen

CKDICIRCCVEGF-Inhibitor

Substanzen

Vascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Division of Nephrology, Massachusetts General Hospital, Boston, MA.
  • Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: priya.deshpande@mountsinai.org.

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Saly, D. L., Eswarappa, M. S., Street, S. E., & Deshpande, P. (2021). Renal Cell Cancer and Chronic Kidney Disease. Advances in Chronic Kidney Disease, 28(5), 460-468.e1. https://doi.org/10.1053/j.ackd.2021.10.008

Vancouver

Saly DL, Eswarappa MS, Street SE, Deshpande P. Renal Cell Cancer and Chronic Kidney Disease. Advances in Chronic Kidney Disease. 2021;28(5):460-468.e1. doi:10.1053/j.ackd.2021.10.008

BibTeX
@article{Saly2021,
  author = {Saly, Danielle L and Eswarappa, Meghana S and Street, Sarah E and Deshpande, Priya},
  title = {Renal Cell Cancer and Chronic Kidney Disease},
  journal = {Advances in Chronic Kidney Disease},
  year = {2021},
  volume = {28},
  number = {5},
  pages = {460--468.e1},
  doi = {10.1053/j.ackd.2021.10.008}
}
Kostenlos starten →